|1.||Vermeer, Cees: 15 articles (01/2016 - 10/2007)|
|2.||Schurgers, Leon J: 12 articles (05/2015 - 01/2007)|
|3.||Boström, Kristina I: 6 articles (03/2015 - 10/2007)|
|4.||Yao, Yucheng: 6 articles (03/2015 - 10/2007)|
|5.||Ataman, O V: 4 articles (01/2015 - 01/2011)|
|6.||Knapen, Marjo H J: 3 articles (01/2016 - 02/2015)|
|7.||Krüger, Thilo: 3 articles (05/2015 - 02/2011)|
|8.||Brandenburg, Vincent M: 3 articles (05/2015 - 05/2010)|
|9.||Gallieni, Maurizio: 3 articles (08/2014 - 11/2005)|
|10.||Floege, Jürgen: 3 articles (08/2014 - 08/2004)|
|1.||Hypertension (High Blood Pressure)
09/01/2008 - "Renal handling of matrix Gla-protein in humans with moderate to severe hypertension."
09/01/2008 - "Since a decrease in renal clearance is a prevalent clinical problem in patients with hypertension, we aimed to study the renal clearance of matrix Gla-protein from the circulation in these patients having a wide range of creatinine clearances. "
|2.||Cardiovascular Diseases (Cardiovascular Disease)
11/01/2013 - "To investigate the relationship of circulating matrix Gla protein (MGP) species with incident cardiovascular disease (CVD) or coronary heart disease (CHD) in type 2 diabetic patients. "
05/01/2015 - "With the discovery that vitamin K-dependent matrix Gla-protein (MGP) is a strong and modifiable factor in the prevention of arterial calcification, vitamin K was put forward as novel treatment option in cardiovascular disease. "
02/01/2014 - "Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease."
05/01/2015 - "Circulating desphospho-uncarboxylated matrix Gla-protein (dp-ucMGP) as well as acute phase markers Interleukin-6 (IL-6), high-sensitive C-reactive protein (hsCRP), tumour necrosis factor-α (TNF-α) and markers for endothelial dysfunction Vascular Cell Adhesion Molecule (VCAM), E-selectin, and Advanced Glycation Endproducts (AGEs) were measured. "
05/01/2009 - "It is now possible to identify factors clearly favoring the formation of VC: TNF-alpha (which stimulates cell necrosis/apoptosis), CRP, oxidized lipids, AGEs, leptin, inorganic phosphate, high calcium-phosphorus product (CaxPO(4)), calcium, 1,25-OH(2)D(3) and Vitamin D(3), PTHrP (via an intracrine pathway), cyclic AMP, TGF-beta, bone morphogenic protein 2 (BMP2) and factors protective against the formation of VC: magnesium, HDL, inorganic pyrophosphate, albumin, ahsg/fetuin A, osteopontin (OPN), osteoprotegerin (OPG), osteonectin (ON), bone morphogenic protein 7 (BMP7), klotho, PTHrP (via a paracrine pathway), matrix gla protein (MGP), PTH (via Msx2) and vitamin K. "
|4.||Kidney Diseases (Kidney Disease)
05/01/2015 - "Plasma protein growth arrest-specific 6 (GAS6) and matrix Gla protein (MGP) are crucial mediators of vascular calcification and are involved in the development of vascular complications in chronic kidney diseases. "
01/01/2011 - "Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease."
11/01/2005 - "Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients."
04/01/2010 - "The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report."
08/01/2014 - "In chronic kidney disease, vitamin K-dependent proteins, including the calcification inhibitor matrix Gla protein, are largely uncarboxylated indicating that functional vitamin K deficiency may contribute to uremic vascular calcification. "
|5.||Vascular Diseases (Vascular Disease)
07/01/2014 - "Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease."
08/20/2010 - "To investigate the effect of altered expression of matrix Gla protein (MGP), an inhibitor of BMP, on vascular disease. "
05/09/2008 - "Arterial calcification is ubiquitous in vascular disease and is, in part, prevented by matrix Gla protein (MGP). "
01/15/2016 - "The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease."
05/01/2014 - "In this study, we investigated in 79 patients with psoriasis compared to 80 healthy volunteers different biomarkers that play a role in vascular disease and inflammation, such as C-reactive protein (CRP), human soluble CD40 ligand (sCD40L), oxidized low-density lipoprotein (ox-LDL), human matrix Gla protein (MGP) and fetuin-A. "
|9.||Parathyroid Hormone-Related Protein
|1.||Prostheses and Implants (Prosthesis)
|2.||Homologous Transplantation (Allograft)
|3.||Heterologous Transplantation (Xenotransplantation)
|4.||Renal Dialysis (Hemodialysis)
|5.||Drug Therapy (Chemotherapy)